MyCare - Patients: View your medical records securely online here.
Log in Learn More

A Phase III, Multicenter, Placebo-controlled, Randomized, Double-blind Study To Evaluate the Safety and Efficacy of PROCHYMAL™ (Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Induction of Remission In Subjects Experiencing Treatment-refractory Moderate-to-Severe Crohn's Disease - Protocol 603. Sponsored by Osiris Therapeutics

IRB Number: 1057A
Notes: Gastroenterology Stem Cell
Status: Not Enrolling
Start Date: October 01, 2007
Principal Name: Kevin Casey, MD
Contact Name: Tia DeRosa, NP, Office for Clinical Research
Phone: (585) 922-3536